ArticleScientific reports2025
Assessment of neurobehavioral and histopathological impacts of graphene quantum Dots in NMRI mice.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graphene quantum dots (GQDs) are attracting significant interest in biomedicine due to their unique properties. While most studies have focused on the general toxicity of GQDs, our understanding of their neurotoxicity remains limited. This study aims to elucidate the neurotoxic effects of GQDs using in vivo experimental models. Adult male NMRI mice were administered GQDs via gavage at doses of 10, 20, and 40 mg/kg for 30 days. Locomotor activity, anxiety-like behaviors, and learning and memory abilities were assessed using the open-field test, elevated-plus maze (EPM) test, and passive avoidance (PA) test, respectively. Oxidative stress markers in hippocampal tissue were analyzed, and histopathological alterations were evaluated. The results from behavioral tests, as well as histological and biochemical evaluations, demonstrated that low doses of GQDs significantly impaired memory function and increased anxiety. High doses of GQDs notably reduced motor activity. Additionally, there was an accumulation of malondialdehyde (MDA) and a reduction in catalase (CAT) activity in hippocampal tissue. Histopathological assessments revealed significant alterations in the hippocampal tissue of GQD-exposed mice. These findings indicate that 30-day exposure to GQDs results in behavioral disturbances and neuronal cell changes in mice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.